{
    "2021-04-29": [
        [
            {
                "time": "",
                "original_text": "疫苗接种黄金期，碧迪医疗与智飞生物签约",
                "features": {
                    "keywords": [
                        "疫苗",
                        "接种",
                        "黄金期",
                        "碧迪医疗",
                        "智飞生物",
                        "签约"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "疫苗概念股全线回撤，之江生物、东方生物跌逾15%",
                "features": {
                    "keywords": [
                        "疫苗",
                        "概念股",
                        "回撤",
                        "之江生物",
                        "东方生物",
                        "跌逾15%"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}